Hopp til innhold
c-myc
  • Hjem
  • Om oss
    • Hendelser
    • C-MYC Styre og Organisering
    • Faglig råd
    • Samarbeidspartnere
    • Kontakt
  • For pasienter
  • Forskning
    • Kliniske forkninsstudier
    • Research projects connected to the biobank
    • Publikasjoner Bjørn Tore Gjertsen
    • Publikasjoner Simona Chera
    • Publikasjoner Eivind Valen
  • Gjertsen Lab
  • Chera Lab
  • Valen Lab

Author: Tuyen Hoang

Nordic AML Meeting - Bergen September 16-18, 2026

Nordic AML Meeting – Bergen September 16-18, 2026

Postet 19. juni 2026 av Tuyen Hoang

We are delighted to invite you to the upcoming Nordic AML meeting, taking place in Bergen – September 16-18, 2026. Join us not only for an inspiring scientific program filled LES MER

Postet i News

Oriol Castells and Stein-Erik Gullaksen at the Meet-the-Expert (MTE) – EHA2026 Congress in Stockholm

Postet 16. juni 202616. juni 2026 av Tuyen Hoang

Congratulations to Oriol Castells and Stein-Erik Gullaksen for their excellent cutting-edge research work presented at EHA2026 Congress in Stockholm (June 11–14, 2026). Both were chosen to be among the experts LES MER

Postet i News
Recap: Workshop "Statistics in Clinical Studies"

Recap: Workshop “Statistics in Clinical Studies”

Postet 18. mai 2026 av Tuyen Hoang

On May 7–8th 2026, the K.G. Jebsen Centre for Myeloid Blood Cancer CMYC, led by Professor Bjørn Tore Gjertsen, organized for the first time an interactive workshop on the topic LES MER

Postet i News
VITAL-CML trial has started with the first patient

VITAL-CML trial has started with the first patient

Postet 27. april 202611. mai 2026 av Tuyen Hoang

For the first time in the world, a patient with chronic leukemia is being injected with cancer cells in the hope of becoming cancer‑free as posted on nrk.no and on LES MER

Postet i News
Posts navigation
Older posts →

Upcoming Events

sep 16
september 16 - september 18

Nordic AML Meeting 2026 – Bergen

sep 16
8:00 - 17:00

CMYC SAB Meeting

Vis kalender
MORE NEWS

The First CML Patient Received Vididencel Vaccine NRK news, NRK TV

"HUVAMER receives TMF funding for AML research" - CCBIO Newsletter October 2025

Support from the Norwegian Cancer Society 2024

New Hope for CML patients

Direktør

Bjørn Tore Gjertsen

Professor, MD PhD

Meddirektør

Simona Chera

Professor, Ph.D

Arkiv

EXTERNAL LINKS

The Research Council of Norway

The Norwegian Cancer Society

The Trond Mohn Research Foundation

Nordic AML Group

Nordic CML Study Group

The HOVON (Stichting Hemato-Oncologie voor Volwassenen Nederland)

CCBIO - Center for Cancer Biomarkers

Theme by Out the Box
Logg inn
en_USEN
en_USEN